Mouse and other rodent models of C to U RNA editing

Methods in Molecular Biology

Volumn 718, Issue , 2011, Pages 121-135

  Blanc, Valerie ^a   Davidson, Nicholas O ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apobec 1; Diet; Hepatocytes; Hormonal regulation; Lipid metabolism; Primer extension; RNA editing; Subcellular distribution

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 1; APOLIPOPROTEIN B100; APOLIPOPROTEIN B48; CYTIDINE; HOLOENZYME; MESSENGER RNA; URIDINE; APOLIPOPROTEIN B; APOLIPOPROTEIN B MRNA EDITING ENZYME; CYTIDINE DEAMINASE; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DEAMINATION; GENE EXPRESSION; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; RNA EDITING; ANIMAL; ARTICLE; CELL CULTURE; DOWN REGULATION; GENETICS; LIPID METABOLISM; LIVER CELL; METABOLISM; TRANSGENIC MOUSE;

ANIMALS; APOLIPOPROTEINS B; CELLS, CULTURED; CYTIDINE; CYTIDINE DEAMINASE; DOWN-REGULATION; HEPATOCYTES; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; LIPID METABOLISM; MICE; MICE, TRANSGENIC; RATS; RNA EDITING; RNA, MESSENGER; URIDINE;

EID: 84855479746     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-018-8_7     Document Type: Chapter

References (37)

1. Blanc, V., and Davidson, N. O. (2003) C-to-U RNA editing: mechanisms leading to genetic diversity. J Biol Chem 278, 1395-8.
2. Greeve, J., Altkemper, I., Dieterich, J. H., Greten, H., and Windler, E. (1993) Apolipoprotein B mRNA editing in 12 different mammalian species: hepatic expression is reflected in low concentrations of apoB-containing plasma lipoproteins. J Lipid Res 34, 1367-83.
3. Giannoni, F., Bonen, D. K., Funahashi, T., Hadjiagapiou, C., Burant, C. F., and Davidson, N. O. (1994) Complementation of apolipoprotein B mRNA editing by human liver accompanied by secretion of apolipoprotein B48. J Biol Chem 269, 5932-6.
4. Davidson, N. O., and Shelness, G. S. (2000) Apolipoprotein B: mRNA editing, lipoprotein assembly and presecretory degradation. Annu Rev Nutr 20, 169-93.
5. Teng, B., Burant, C. F., and Davidson, N. O. (1993) Molecular cloning of an apolipoprotein B messenger RNA editing protein. Science 260, 1816-9.
6. Mehta, A., Kinter, M. T., Sherman, N. E., and Driscoll, D. M. (2000) Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA. Mol Cell Biol 20, 1846-54.
7. Lellek, H., Kirsten, R., Diehl, I., Apostel, F., Buck, F., and Greeve, J. (2000) Purification and molecular cloning of a novel essential component of the apolipoprotein B mRNA editing enzyme-complex. J Biol Chem 275, 19848-56.
8. Blanc, V., Henderson, J. O., Newberry, E. P., Kennedy, S., Luo, J., and Davidson, N. O. (2005) Targeted deletion of the murine apobec-1 complementation factor (acf) gene results in embryonic lethality. Mol Cell Biol 25, 7260-9.
9. Teng, B., Black, D. D., and Davidson, N. O. (1990) Apolipoprotein B messenger RNA editing is developmentally regulated in pig small intestine: nucleotide comparison of apolipoprotein B editing regions in five species. Biochem Biophys Res Commun 173, 74-80.
10. Henderson, J. O., Blanc, V., and Davidson, N. O. (2001) Isolation, characterization and developmental regulation of the human apobec-1 complementation factor (ACF) gene. Biochim Biophys Acta 1522, 22-30.
11. Mansouri, A., Chowdhury, K., and Gruss, P. (1998) Follicular cells of the thyroid gland require Pax8 gene function. Nat Genet 19, 87-90.
12. Flamant, F., Poguet, A. L., Plateroti, M., Chassande, O., Gauthier, K., Streichenberger, N., Mansouri, A., and Samarut, J. (2002) Congenital hypothyroid Pax8(-/-) mutant mice can be rescued by inactivating the TRalpha gene. Mol Endocrinol 16, 24-32.
13. Mukhopadhyay, D., Plateroti, M., Anant, S., Nassir, F., Samarut, J., and Davidson, N. O. (2003) Thyroid hormone regulates hepatic triglyceride mobilization and apolipoprotein B messenger ribonucleic acid editing in a murine model of congenital hypothyroidism. Endocrinology 144, 711-9.
14. Philips, M. S., Liu, Q., Hammond, H. A., Dugan, V., Hey, P. J., Caskey, C. T., and Hess, J. F. (1996) Leptin receptor missense in the fatty Zucker rat. Nature Genet 13, 18-19.
15. von Wronski, M. A., Hirano, K. I., Cagen, L. M., Wilcox, H. G., Raghow, R., Thorngate, F. E., Heimberg, M., Davidson, N. O., and Elam, M. B. (1998) Insulin increases expression of apobec-1, the catalytic subunit of the apolipoprotein B mRNA editing complex in rat hepatocytes. Metabolism 47, 869-73.
16. Elam, M. B., von Wronski, M. A., Cagen, L., Thorngate, F., Kumar, P., Heimberg, M., and Wilcox, H. G. (1999) Apolipoprotein B mRNA editing and apolipoprotein gene expression in the liver of hyperinsulinemic fatty Zucker rats: relationship to very low density lipoprotein composition. Lipids 34, 809-16.
17. Sowden, M. P., Ballatori, N., Jensen, K. L., Reed, L. H., and Smith, H. C. (2002) The editosome for cytidine to uridine mRNA editing has a native complexity of 27S: identification of intracellular domains containing active and inactive editing factors. J Cell Sci 115, 1027-39.
18. Lehmann, D. M., Galloway, C. A., Sowden, M. P., and Smith, H. C. (2006) Metabolic regulation of apoB mRNA editing is associated with phosphorylation of APOBEC-1 complementation factor. Nucleic Acids Res 34, 3299-308.
19. Wiegman, C. H., Bandsma, R. H., Ouwens, M., van der Sluijs, F. H., Havinga, R., Boer, T., Reijngoud, D. J., Romijn, J. A., and Kuipers, F. (2003) Hepatic VLDL production in ob/ob mice is not stimulated by massive de novo lipogenesis but is less sensitive to the suppressive effects of insulin. Diabetes 52, 1081-9.
20. Lee, G. H., Proenca, R., Montez, J. M., Carroll, K. M., Darvishzadeh, J. G., Lee, J. I., and Friedman, J. M. (1996) Abnormal splicing of the leptin receptor in diabetic mice. Nature 379, 632-5.
21. Leiter, E. H., Coleman, D. L., Eisenstein, A. B., and Strack, I. (1980) A new mutation (db3j) at the diabetes locus in strain 129/j mice. Physiological and histological characterization. Diabetologia 19, 58-65.
22. Kobayashi, K., Forte, T. M., Taniguchi, S., Ishida, B. Y., Oka, K., and Chan, L. (2000) The db/db mouse, a model for diabetic dyslipidemia: molecular characterization and effects of Western diet feeding. Metabolism 49, 22-31.
23. Hirano, K., Young, S. G., Farese, R. V., Jr., Ng, J., Sande, E., Warburton, C., Powell-Braxton, L. M., and Davidson, N. O. (1996) Targeted disruption of the mouse apobec-1 gene abolishes apolipoprotein B mRNA editing and eliminates apolipoprotein B48. J Biol Chem 271, 9887-90.
24. Nakamuta, M., Chang, B. H., Zsigmond, E., Kobayashi, K., Lei, H., Ishida, B. Y., Oka, K., Li, E., and Chan, L. (1996) Complete phenotypic characterization of apobec-1 knockout mice with a wild-type genetic background and a human apolipoprotein B trasngenic background and restoration of apolipoprotein B mRNA editing by somatic gene transfer of Apobec-1. J Biol Chem 271, 25981-8.
25. Yamanaka, S., Balestra, M. E., Ferrell, L. D., Fan, J., Arnold, K. S., Taylor, S., Taylor, J. M., and Innerarity, T. L. (1995) Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. Proc Natl Acad Sci U S A 92, 8483-7.
26. Yamanaka, S., Poksay, K. S., Driscoll, D. M., and Innerarity, T. L. (1996) Hyperediting of multiple cytidines of apolipoprotein B mRNA by APOBEC-1 requires auxiliary protein(s) but not a mooring sequence motif. J Biol Chem 271, 11506-10.
27. Kistner, A., Gossen, M., Zimmermann, F., Jerecic, J., Ullmer, C., Lubbert, H., and Bujard, H. (1996) Doxycycline-meidated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci U S A 93, 10933-8.
28. Hersberger, M., Patarroyo-White, S., Qian, X., Arnold, K. S., Rohrer, L., Balestra, M. E., and Innerarity, T. L. (2003) Regulatable liver expression of the rabbit apolipoprotein B mRNA-editing catalytic polypeptide 1 (APOBEC-1) in mice lacking endogenous APOBEC-1 leads to aberrant hyperediting. Biochem J 369, 255-62.
29. Davidson, N. O., Powell, L. M., Wallis, S. C., and Scott, J. (1988) Thyroid hormone modulates the introduction of a stop codon in rat liver apolipoprotein B messenger RNA. J Biol Chem 263, 13482-5.
30. Plateroti, M., Chassande, O., Fraichard, A., Gauthier, K., Freund, J. N., Samarut, J., and Kedinger, M. (1999) Involvement of T3Ralpha-and beta-receptor subtypes in mediation of T3 functions during postnatal murine intestinal development. Gastroenterology 116, 1367-78.
31. Srivastava, R. A. (1995) Increased apoB100 mRNA in inbred strains of mice by estrogen is caused by decreased RNA editing protein mRNA. Biochem Biophys Res Commun 212, 381-7.
32. Lau, P. P., Cahill, D. J., Zhu, H. J., and Chan, L. (1995) Ethanol modulates apolipoprotein B mRNA editing in the rat. J Lipid Res 36, 2069-78.
33. Baum, C. L., Teng, B. B., and Davidson, N. O. (1990) Apolipoprotein B messenger RNA editing in the rat liver. Modulation by fasting and refeeding a high carbohydrate diet. J Biol Chem 265, 19263-70.
34. MacGinnitie, A. J., Anant, S., and Davidson, N. O. (1995) Mutagenesis of apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme reveals distinct domains that mediate cytosine nucleoside deaminase, RNA binding and RNA editing activity. J Biol Chem 270, 14768-75.
35. Funahashi, T., Giannoni, F., DePaoli, A. M., Skarosi, S. F., and Davidson, N. O. (1995) Tissue-specific, developmental and nutritional regulation of the gene encoding the catalytic subunit of the rat apolipoprotein B mRNA editing enzyme: functional role in the modulation of apoB mRNA editing. J Lipid Res 36, 414-28.
36. Blanc, V., Henderson, J. O., Kennedy, S., and Davidson, N. O. (2001) Mutagenesis of apobec-1 complementation factor reveals distinct domains that modulate RNA binding, protein-protein interaction with apobec-1 and complementation of C to U RNA editing activity. J Biol Chem 276, 46386-93.
37. Bonen, D. K., Nassir, F., Hausman, A. M., and Davidson, N. O. (1998) Inhibition of N-linked glycosylation results in retention of intracellular apo(a) in hepatoma cells, although nonglycosylated and immature forms of apolipoprotein(a) are competent to associate with apolipoprotein B-100 in vitro. J Lipid Res 39, 1629-40.